Price T Rowe Associates Inc Incyte Corp Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Incyte Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 608,444 shares of INCY stock, worth $43.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
608,444
Previous 225,112 170.29%
Holding current value
$43.2 Million
Previous $13.6 Million 194.69%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$57.33 - $68.61 $22 Million - $26.3 Million
383,332 Added 170.29%
608,444 $40.2 Million
Q2 2024

Aug 14, 2024
SELL
$51.18 - $63.75 $21.4 Million - $26.7 Million
-418,544 Reduced 65.03%
225,112 $13.6 Million
Q1 2024

May 15, 2024
SELL
$56.55 - $66.59 $14 Million - $16.4 Million
-246,850 Reduced 27.72%
643,656 $36.7 Million
Q4 2023

Feb 14, 2024
SELL
$52.16 - $64.19 $8.33 Million - $10.2 Million
-159,652 Reduced 15.2%
890,506 $55.9 Million
Q3 2023

Nov 14, 2023
SELL
$57.77 - $65.93 $8.41 Million - $9.6 Million
-145,595 Reduced 12.18%
1,050,158 $60.7 Million
Q2 2023

Aug 14, 2023
SELL
$60.95 - $75.51 $37.9 Million - $47 Million
-622,594 Reduced 34.24%
1,195,753 $74.4 Million
Q1 2023

May 15, 2023
SELL
$70.23 - $86.01 $7.16 Million - $8.77 Million
-101,942 Reduced 5.31%
1,818,347 $131 Million
Q4 2022

Feb 14, 2023
SELL
$67.18 - $84.11 $26 Million - $32.5 Million
-386,583 Reduced 16.76%
1,920,289 $154 Million
Q3 2022

Nov 14, 2022
SELL
$66.18 - $82.86 $72.8 Million - $91.1 Million
-1,099,310 Reduced 32.27%
2,306,872 $154 Million
Q2 2022

Aug 15, 2022
SELL
$66.18 - $83.18 $85.1 Million - $107 Million
-1,286,023 Reduced 27.41%
3,406,182 $259 Million
Q1 2022

May 16, 2022
SELL
$66.02 - $79.71 $170 Million - $206 Million
-2,579,483 Reduced 35.47%
4,692,205 $373 Million
Q4 2021

Feb 14, 2022
SELL
$63.34 - $74.11 $737 Million - $863 Million
-11,638,526 Reduced 61.55%
7,271,688 $534 Million
Q3 2021

Nov 15, 2021
SELL
$68.67 - $84.02 $663 Million - $812 Million
-9,660,276 Reduced 33.81%
18,910,214 $1.3 Billion
Q2 2021

Aug 16, 2021
SELL
$79.87 - $87.53 $119 Million - $130 Million
-1,488,332 Reduced 4.95%
28,570,490 $2.4 Billion
Q1 2021

May 17, 2021
SELL
$76.02 - $100.5 $193 Million - $255 Million
-2,535,860 Reduced 7.78%
30,058,822 $2.44 Billion
Q4 2020

Feb 16, 2021
BUY
$80.74 - $97.7 $2.63 Billion - $3.18 Billion
32,594,682 New
32,594,682 $2.84 Billion

Others Institutions Holding INCY

# of Institutions
642
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email